SCHEMBL9915090

SCHEMBL9915090

CC(C(=O)SNC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 2/20 0.48
LMNA P02545 3/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
MDM4 O15151 1/20 0.43
TP53 P04637 1/20 0.43
MDM2 Q00987 1/20 0.43
EPHX2 P34913 1/20 0.42
RAB9A P51151 1/20 0.42
HPGD P15428 1/20 0.42
APAF1 O14727 1/20 0.42
ROCK2 O75116 1/20 0.42
RPS6KA5 O75582 1/20 0.42
MAP4K4 O95819 1/20 0.42
CDK1 P06493 1/20 0.42
CSF1R P07333 1/20 0.42
PRKACA P17612 1/20 0.42
FLT1 P17948 1/20 0.42
RPS6KB1 P23443 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9915160 0.84 MDM4 (0.54) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL9915091 0.83 TDP1 (0.50) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL27515367 0.76 ALOX15 (0.56) ALDH1A1SMN1; SMN2NPC1RAB9AHPGD
SCHEMBL9915084 0.74 HDAC3 (0.50) LMNAALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL28402516 0.74 GRM7 (0.49) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL1101522 0.73 ALDH1A1 (0.77) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL5968858 0.73 ALDH1A1 (0.77) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL751213 0.73 ALDH1A1 (0.77) GPR139LMNAALDH1A1SMN1; SMN2NPC1
SCHEMBL5094452 0.72 PTGS2 (0.48) LMNAALDH1A1SMN1; SMN2HPGDMAPK1
SCHEMBL9274738 0.72 ALOX15 (0.52) ALDH1A1SMN1; SMN2NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096504-B2 Controlled chemical release of hydrogen sulfide WASHINGTON STATE UNIVERSITY (US) 2015-08-04 US disclosed
US-9096504-B2 Controlled chemical release of hydrogen sulfide WASHINGTON STATE UNIVERSITY (US) 2015-08-04 US disclosed
US-20130253051-A1 CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE WASHINGTON STATE UNIVERSITY (US) 2013-09-26 US disclosed
US-20130253051-A1 CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE WASHINGTON STATE UNIVERSITY (US) 2013-09-26 US disclosed
WO-2012075242-A2 CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) 2012-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130253051-A1 CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE GSR, AR, GRHPR GPR139 353/4885LMNA 4135/4885ALDH1A1 2368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.